BMS-986458 features three stereocenters, one of which epimerizes easily, Mortensen said. The drug candidate, which would be ...
CureVac N.V. secured funding with GSK amid financial struggles, while a key patent win boosts stock. Click for why my ...
Appeals court upholds J&J win blocking Mylan's generic version of schizophrenia drug Invega Trinza, protecting patent for ...
Addressing the calculation of patent term extensions (PTEs) under the Hatch-Waxman Act, the US Court of Appeals for the Federal Circuit affirmed ...
Safeguards Of Dapagliflozin's Half Billion USD Sales In China: Astrazeneca. Legal News and Analysis - China - Conventus Law ...
A group of senators this week reintroduced a bill titled “The Interagency Patent Coordination and Improvement Act,” which ...
On March 21, the Court of Appeals for the Federal Circuit held in a precedential opinion that legal fees incurred by generic drug companies ...
Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.
The new technology integrates active temperature regulation, precise optical path control, and a versatile form factor.
The global Drug Discovery Services Market , valued at US$14.89 billion in 2024, is forecasted to grow at a robust CAGR of ...
For some Big Pharma companies, sales in China contributed to more than 10 percent of global sales, making China a top market ...
Zacks Investment Research on MSN5dOpinion
5 Large Drug Stocks to Watch as Industry Recovers
The drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due ...